Literature DB >> 21129542

Physiological and clinical characteristics of gastroesophageal reflux after congenital diaphragmatic hernia repair.

Hisayoshi Kawahara1, Hiroomi Okuyama, Keisuke Nose, Hiroshi Nakai, Akihiro Yoneda, Akio Kubota, Masahiro Fukuzawa.   

Abstract

BACKGROUND/
PURPOSE: Gastroesophageal reflux (GER) is an important sequela of congenital diaphragmatic hernia (CDH) repair. This study investigated the physiological and clinical characteristics of GER in CDH survivors.
METHODS: A total of 52 CDH survivors were investigated retrospectively. Esophageal acid exposure was evaluated with 24-h esophageal pH monitoring in all patients, and esophageal anatomical and motor functional abnormalities were examined with videomanometry in 16 patients.
RESULTS: Fundoplication was necessary in 1 patient. Medical treatment with acid suppression or rikkunshito, a traditional Japanese medicine, was successful in nine patients, and the reflux symptoms were ameliorated at the age of 3 years. The percentage of total time the esophageal pH was below 4.0 (reflux index: RI) ranged from 0.1 to 44.3%. No patient with an RI < 10% had reflux symptoms requiring treatment. The basal lower esophageal sphincter (LES) tone ranged from 15 to 35 mmHg (median 25 mmHg). Esophageal peristalsis was preserved in all of the patients examined, except one who had failed peristalsis and poor clearance in the dilated esophagus.
CONCLUSION: The motor function of the esophageal body and LES is usually preserved in CDH survivors despite the wide range of esophageal acid exposure in early infancy. Those with symptomatic GER outgrow it, unless associated with advanced respiratory distress or neurological impairment.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21129542     DOI: 10.1016/j.jpedsurg.2010.08.029

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  7 in total

Review 1.  Gastroesophageal reflux and congenital gastrointestinal malformations.

Authors:  Lucia Marseglia; Sara Manti; Gabriella D'Angelo; Eloisa Gitto; Carmelo Salpietro; Antonio Centorrino; Gianfranco Scalfari; Giuseppe Santoro; Pietro Impellizzeri; Carmelo Romeo
Journal:  World J Gastroenterol       Date:  2015-07-28       Impact factor: 5.742

2.  Lung function in school-aged congenital diaphragmatic hernia patients; a longitudinal evaluation.

Authors:  Leontien C C Toussaint-Duyster; Monique H M van der Cammen-van Zijp; Marjolein Spoel; Harm A W M Tiddens; Dick Tibboel; Rene M H Wijnen; Joost van Rosmalen; Hanneke IJsselstijn
Journal:  Pediatr Pulmonol       Date:  2019-06-13

3.  Long-Term Evaluation of Gastroesophageal Reflux in Neonates with and without Preventive Anti-reflux Surgery at the Time of Congenital Diaphragmatic Hernia Repair.

Authors:  Christoph von Schrottenberg; Susanne Deeg; Christel Weiss; Rüdiger Adam; Lucas M Wessel; Michael Boettcher; Katrin B Zahn
Journal:  Children (Basel)       Date:  2022-07-29

Review 4.  Cancer cachexia--pathophysiology and management.

Authors:  Hajime Suzuki; Akihiro Asakawa; Haruka Amitani; Norifumi Nakamura; Akio Inui
Journal:  J Gastroenterol       Date:  2013-03-20       Impact factor: 7.527

5.  Gastrostomy tube placement in infants with congenital diaphragmatic hernia: Frequency, predictors, and growth outcomes.

Authors:  Sharmistha Rudra; Obinna O Adibe; William F Malcolm; P Brian Smith; C Michael Cotten; Rachel G Greenberg
Journal:  Early Hum Dev       Date:  2016-08-22       Impact factor: 2.699

6.  Potentiation of ghrelin signaling attenuates cancer anorexia-cachexia and prolongs survival.

Authors:  N Fujitsuka; A Asakawa; Y Uezono; K Minami; T Yamaguchi; A Niijima; T Yada; Y Maejima; U Sedbazar; T Sakai; T Hattori; Y Kase; A Inui
Journal:  Transl Psychiatry       Date:  2011-07-26       Impact factor: 6.222

7.  Eosinophilic esophagitis after congenital diaphragmatic hernia.

Authors:  Amelia Licari; Riccardo Castagnoli; Gian Luigi Marseglia
Journal:  Ital J Pediatr       Date:  2016-11-08       Impact factor: 2.638

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.